<DOC>
	<DOCNO>NCT01826461</DOCNO>
	<brief_summary>This study compare safety efficacy three test article foam ( PDI-192 0.1 % Foam , PDI-192 0.15 % Foam , Vehicle Foam ) final commercial product may select future development .</brief_summary>
	<brief_title>An Evaluation PDI-192 0.1 % Comparison PDI-192 0.15 % Treatment Mild Moderate Atopic Dermatitis</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>Subject present clinical diagnosis stable mild moderate atopic dermatitis . Subject use type soap , moisturizers , lotion , cream , ointment , sunscreen skin product , hair product ( shampoo , etc . ) least two week prior study start agrees continue usage product similar frequency entire study . Subject pregnant , lactate plan become pregnant study . Subject require topical systemic medication use topical inflammatory dermatosis therapy could affect course atopic dermatitis study period . Subject use systemic corticosteroid , immunomodulators include leukotriene inhibitor , antimetabolite within 30 day prior study start . Subject use Ultraviolet Light Therapy ( PUVA , UVB , etc . ) within 30 day prior study start . Subject use topical therapy treatment ( may affect ) atopic dermatitis include limited corticosteroid , immunomodulators ( tacrolimus , pimecrolimus , etc . ) , tar , calcipotriene vitamin D preparation , retinoids , antihistamine ( doxepin , diphenhydramine , etc . ) , antibiotic , among others , within 14 day prior study start . Subject desire excessive prolonged exposure ultraviolet light ( e.g. , sunlight , tan bed ) study . Subject use systemic ( oral , IV , etc . ) antibiotic therapy within seven day prior study start . Subject currently enrol investigational drug device study . Subject use investigational drug investigational device treatment within 30 day prior study start .</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>atopic dermatitis</keyword>
	<keyword>eczema</keyword>
	<keyword>PDI-192</keyword>
	<keyword>Precision</keyword>
</DOC>